Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sustained Virologic Response”

138 trials

Showing 20 of 138 results

Not applicableStudy completedNCT04577482
What this trial is testing

Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 42
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Not applicableStudy completedNCT01066819
What this trial is testing

PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,656
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Large-scale testing (Phase 3)UnknownNCT00215839
What this trial is testing

HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy

Who this might be right for
Chronic Hepatitis C Infection in HIV Infected PersonsHIV Infections
Hepatitis Resource Network
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Not applicableStudy completedNCT02103699
What this trial is testing

Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir

Who this might be right for
Hepatitis C Virus
Janssen Scientific Affairs, LLC 315
Not applicableUnknownNCT04724785
What this trial is testing

Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients

Who this might be right for
Sustained Virologic ResponseHepatitis B, Chronic
The Second Affiliated Hospital of Chongqing Medical University 10,000
Large-scale testing (Phase 3)Study completedNCT02487030
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 255
Large-scale testing (Phase 3)Study completedNCT02472886
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 153
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Large-scale testing (Phase 3)Study completedNCT00623428
What this trial is testing

Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 235
Not applicableStudy completedNCT03566966
What this trial is testing

Autoantibodies and Direct-acting Antivirals

Who this might be right for
Viral Hepatitis CTherapy Adverse Effect
University of Bari 191
Not applicableStudy completedNCT03453346
What this trial is testing

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus Infection, Response to Therapy of
Kawin Technology Share-holding Co., Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT00901524
What this trial is testing

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Who this might be right for
Hepatitis
ANRS, Emerging Infectious Diseases 58
Not applicableUnknownNCT01146626
What this trial is testing

Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?

Who this might be right for
Hepatitis C
Ziv Hospital 60
Not applicableStudy completedNCT03884062
What this trial is testing

Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

Who this might be right for
HCC in Chronic HCV Patients With Advanced Liver Fibrosis
Egyptian Liver Hospital 3,000
Large-scale testing (Phase 3)UnknownNCT02646111
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures

Who this might be right for
Hepatitis C
Tel-Aviv Sourasky Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT01225380
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 324
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation